Sun Pharma gets fresh 11 observations from US FDA
pharmabiz.com-15 hours ago
Sun Pharmaceuticals, a Rs. 27,700 crore plus leading Indian pharma entity, has received yet another blow from US FDA. The company's Dadra facility ...
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
No comments:
Post a Comment